Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3002327
Reference Type
Journal Article
Title
Identification, Synthesis, and Characterization of Unknown Impurity in the Famotidine Powder for Oral Suspension Due to Excipient Interaction by UPLC-MS/MS and NMR
Author(s)
Hotha, KK; Patel, T; Roychowdhury, S; Subramanian, V
Year
2015
Is Peer Reviewed?
Yes
Journal
Journal of Liquid Chromatography and Related Technologies
ISSN:
1082-6076
EISSN:
1520-572X
Volume
38
Issue
9
Page Numbers
977-985
DOI
10.1080/10826076.2014.999201
Web of Science Id
WOS:000351907600007
Abstract
Excipients interactions with the drug product are the most predominant causes for a product failure. Regulated guidelines have stringent limits for the unknown impurities observed in the pharmaceutical dosage forms. The quality of the excipients plays an important role in the finished product dosage forms which will form unknown impurities due to the impurities present in the excipients. Sometimes change in excipient manufacturer/lot gives not only the formulation related inconsistencies but hard-hitting encounters to analytical research due to their interactions with the drug product and formation of unknown impurities. Flavors used in the formulation process are the most possible origins to form impurities due to the trace level presence of aldehydes and ketones that were apparently used for its aroma. In this article identification, synthesis, and characterization of unknown impurity formed in the famotidine oral solution due to benzaldehyde which is present in the excipient of cherry flavor used in the formulation process. The samples of this impurity were investigated by HPLC and ultra performance liquid chromatography (UPLC)-MS/MS to generate the mechanism of the impurity formation. The impurity was synthesized, separated, and purified by preparative HPLC and characterized by UV, MS/MS, and NMR Results.
Keywords
oral suspension; impurities; degradation; development; famotidine; characterization
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity